These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35021169)

  • 41. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysarthric sentence intelligibility: contribution of iconic gestures and message predictiveness.
    Garcia JM; Dagenais PA
    J Speech Lang Hear Res; 1998 Dec; 41(6):1282-93. PubMed ID: 9859884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting Intelligibility Deficits in Parkinson's Disease With Perceptual Speech Ratings.
    Chiu YF; Neel A
    J Speech Lang Hear Res; 2020 Feb; 63(2):433-443. PubMed ID: 32097080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
    Kuo C; Tjaden K
    J Commun Disord; 2016; 62():30-44. PubMed ID: 27219893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validation and cross-linguistic adaptation of the Frenchay Dysarthria Assessment (FDA-2) speech intelligibility tests: Hebrew version.
    Icht M; Bergerzon-Bitton O; Ben-David BM
    Int J Lang Commun Disord; 2022 Sep; 57(5):1023-1049. PubMed ID: 35714104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acoustic vowel analysis and speech intelligibility in young adult Hebrew speakers: Developmental dysarthria versus typical development.
    Carl M; Icht M
    Int J Lang Commun Disord; 2021 Mar; 56(2):283-298. PubMed ID: 33522087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of clear speech intervention program on speech intelligibility in persons with idiopathic Parkinson's disease: A pilot study.
    Shin H; Shivabasappa P; Koul R
    Int J Speech Lang Pathol; 2022 Feb; 24(1):33-41. PubMed ID: 34229555
    [No Abstract]   [Full Text] [Related]  

  • 48. Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers.
    Beijer LJ; Rietveld AC; Ruiter MB; Geurts AC
    Clin Linguist Phon; 2014 Dec; 28(12):927-50. PubMed ID: 25025268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing speech intelligibility of pathological speech: test types, ratings and transcription measures.
    Xue W; van Hout R; Cucchiarini C; Strik H
    Clin Linguist Phon; 2023 Jan; 37(1):52-76. PubMed ID: 34955083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A closer look at transcription intelligibility for speakers with dysarthria: evaluation of scoring paradigms and linguistic errors made by listeners.
    Hustad KC
    Am J Speech Lang Pathol; 2006 Aug; 15(3):268-77. PubMed ID: 16896176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the prosodic characteristics of the speech of people with Parkinson's disease and Friedreich's ataxia with neurologically normal speakers.
    Le Dorze G; Ryalls J; Brassard C; Boulanger N; Ratté D
    Folia Phoniatr Logop; 1998; 50(1):1-9. PubMed ID: 9509733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acoustic and perceptual correlates of faster-than-habitual speech produced by speakers with Parkinson's disease and multiple sclerosis.
    Kuo C; Tjaden K; Sussman JE
    J Commun Disord; 2014; 52():156-69. PubMed ID: 25287378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.
    Miller N; Allcock L; Jones D; Noble E; Hildreth AJ; Burn DJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1188-90. PubMed ID: 17400592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sentence-Level Movements in Parkinson's Disease: Loud, Clear, and Slow Speech.
    Kearney E; Giles R; Haworth B; Faloutsos P; Baljko M; Yunusova Y
    J Speech Lang Hear Res; 2017 Dec; 60(12):3426-3440. PubMed ID: 29209727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perception of coarticulatory information in normal speech and dysarthria.
    Tjaden K; Sussman J
    J Speech Lang Hear Res; 2006 Aug; 49(4):888-902. PubMed ID: 16908883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Effect of Noise on Relationships Between Speech Intelligibility and Self-Reported Communication Measures in Tracheoesophageal Speakers.
    Eadie TL; Otero DS; Bolt S; Kapsner-Smith M; Sullivan JR
    Am J Speech Lang Pathol; 2016 Aug; 25(3):393-407. PubMed ID: 27379754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An exploration of listener variability in intelligibility judgments.
    McHenry M
    Am J Speech Lang Pathol; 2011 May; 20(2):119-23. PubMed ID: 21317298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How expertise and language familiarity influence perception of speech of people with Parkinson's disease.
    Verkhodanova V; Coler M; Jonkers R; Lowie W
    Clin Linguist Phon; 2022 Mar; 36(2-3):165-182. PubMed ID: 34809519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Educational Information Improves Listener Attitudes Toward People With Dysarthria Secondary to Parkinson's Disease.
    Fletcher AR; Potts MW; Borrie SA
    Am J Speech Lang Pathol; 2023 May; 32(3):1099-1109. PubMed ID: 36881856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.